Herbas VPB

Print
EN | LT
LT - Bispecifiniai EGFR/c-Met antikūnai
EN - BISPECIFIC EGFR/C-MET ANTIBODIES

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/00 (2006.01)
A61K 39/395 (2006.01)
A61K 31/4545 (2006.01)
A61K 31/517 (2006.01)
A61K 45/06 (2006.01)
A61K 31/437 (2006.01)
A61K 31/5377 (2006.01)
A61K 33/24 (2006.01)
C07K 16/28 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 2922872
(13) Kind of document T
(96) European patent application number 13856592.4
Date of filing the European patent application 2013-11-21
(97) Date of publication of the European application 2015-09-30
(45) Date of publication and mention of the grant of the patent 2018-10-10
(46) Date of publication of the claims translation 2018-12-27
PCT application
(86) Number PCT/US2013/071288
Date 2013-11-21
PCT application publication
(87) Number WO 2014/081954
Date 2014-05-30
Priority applications
(30) Number Date Country code
201261728912 P 2012-11-21 US
201361782550 P 2013-03-14 US
201361809541 P 2013-04-08 US
201361864717 P 2013-08-12 US
201361892797 P 2013-10-18 US
Inventors
(72)
CHIU, Mark, US
MOORES, Sheri, US
NEIJSSEN, Joost, NL
PARREN, Paul, NL
SCHUURMAN, Janine, NL
Grantee
(73) Janssen Biotech, Inc., 800/850 Ridgeview Drive, Horsham, PA 19044, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Bispecifiniai EGFR/c-Met antikūnai
  BISPECIFIC EGFR/C-MET ANTIBODIES
Last renewal fee
Payment date Validity (years) Amount
2025-10-21 13 289.00 EUR
Next renewal fee
2026-11-21